Researchers are leveraging Ohio Supercomputer Center resources to develop computer-assisted diagnosis tools that will provide pathologists grading Follicular Lymphoma samples with quicker, more consistently ...
Jan 31, 2011
not rated yet
0
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, today announced the publication of breakthrough new research in the Proceedings of ...
Nov 15, 2010
not rated yet
0
Long-term treatment with anti-cancer medication Rituxan, produced by Swiss laboratory Roche, can cut the recurrence of follicular lymphoma in some patients by half, a new study said.
May 21, 2010
5 / 5 (1)
0
California and Arizona researchers have identified a gene variant that carries nearly twice the risk of developing an increasingly common type of blood cancer, according to a study published online today by the science journal ...
Jul 20, 2009
5 / 5 (1)
0
